Related Experiment Video
Updated: Jul 30, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Cost of treatment failure for major depression: direct costs of continued treatment
1Yale School of Medicine, Department of Psychiatry, Connecticut Mental Health Center, USA. Bruce.Baker@Yale.Edu
Abstract:
Understanding subsequent costs of treating patients who fail initial treatment for depression is critical in cost-effectiveness analysis. This prospective observational study calculated such costs in a community mental health center. Total mean annual direct per-patient costs were $6,818 to $8,661. This total was markedly higher than those reported in studies that were based partially on the assumptions of expert panels rather than observed utilization rates. These results suggest that in settings similar to the present study, antidepressant treatments with higher failure rates may carry a marked hidden cost disadvantage.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: MDD and Dysthymia
Electroconvulsive Therapy
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

